American Society of Hematology, Blood, 17(126), p. 1996-2004, 2015
DOI: 10.1182/blood-2015-05-644039
Full text: Download
Key PointsCombination of ISS and the EMC92 gene classifier is a novel clinically applicable risk classification for survival in multiple myeloma. ISS has clear independent additive prognostic value in combination with GEP classifiers or FISH markers.